Thrombus aspiration in primary percutaneous coronary intervention for STEMI patients with high thrombus burden

NCT ID NCT04212494

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

This is a prospective, multicenter, open-label, randomized, controlled, parallel group study, in which ST-segment Elevation Myocardial Infarction (STEMI) patients with high thrombus burden(TIMI thrombus grade ≥3) are included. Patients are randomized to be treated with or without manual thrombus aspiration(TA) during primary percutaneous coronary intervention(PPCI) by a ratio of 1:1.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3,838 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2020

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years; 2. STEMI patients undergoing primary PCI within 12 hours after the onset of symptoms; 3. High thrombus burden after guidewire passes the lesion (TIMI thrombus grade ≥3); 4. Informed consent must be voluntary; Exclusion Criteria: 1. Haemodynamic instability or cardiogenic shock; 2. After thrombolytic therapy; 3. The predicted survival time is less than 6 months due to non-cardiac disease; 4. History of coronary artery bypass grafting; 5. Participate in other researches within 30 days; 6. Preoperative gastrointestinal bleeding or contraindications to dual antiplatelet therapy; 7. Patients were considered unsuitable by other researchers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ST-segment elevation myocardial infarction (stemi) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    50 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Affiliated Hospital, Weifang Medical University

    RECRUITING

    Weifang, Shandong, 261031, China

  • First People's Hospital of Foshan

    RECRUITING

    Foshan, Guangdong, 528000, China

  • First People's Hospital of Shunde (Affiliated Hospital at Shunde, Southern Medical University)

    RECRUITING

    Foshan, Guangdong, 528300, China

  • Fujian Provincial Hospital

    NOT_YET_RECRUITING

    Fuzhou, Fujian, 350001, China

  • GanZhou Municopal Hospital

    NOT_YET_RECRUITING

    Ganzhou, Jiangxi, 341000, China

  • Guangdong Provincial Hospital of traditional Chinese Medicine

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510120, China

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510000, China

  • Guangzhou General Hospital of Guangzhou Military Command

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510010, China

  • Guangzhou Panyu Central Hospital

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510000, China

  • Guilin people's Hospital

    NOT_YET_RECRUITING

    Guilin, Guangxi, 541002, China

  • Hainan People's Hospital

    NOT_YET_RECRUITING

    Haikou, Hainan, 570311, China

  • Huadu District People's Hospital of Guangzhou

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510800, China

  • Huangpu Division of The First Affiliated Hospital, Sun Yat-sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510700, China

  • Huizhou Third People's Hospital

    NOT_YET_RECRUITING

    Huizhou, Guangdong, 516002, China

  • Jiangmen Central Hospital

    RECRUITING

    Jiangmen, Guangdong, 529030, China

  • Kaiping Central Hospital

    RECRUITING

    Kaiping, Guangdong, 529300, China

  • Kashgar first people's Hospital

    RECRUITING

    Kashgar, Xinjiang, 844000, China

  • Maoming People's Hospital

    NOT_YET_RECRUITING

    Maoming, Guangdong, 525000, China

  • Nanfang Hospital

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510515, China

  • Nanxiong people's Hospital

    RECRUITING

    Xiongzhou, Guangdong, 512400, China

  • Peking University Shenzhen Hospital

    NOT_YET_RECRUITING

    Shenzhen, Guangdong, 518035, China

  • People's Hospital of Yangjiang City

    RECRUITING

    Yangjiang, Guangdong, 529500, China

  • Shangyou Hospital

    RECRUITING

    Ganzhou, Jiangxi, 341200, China

  • Shaoxing people's Hospital

    NOT_YET_RECRUITING

    Shaoxing, Zhejiang, 312000, China

  • Shenzhen Bao'an District People's Hospital

    RECRUITING

    Shenzhen, Guangdong, 518101, China

  • Shenzhen People's Hospital

    RECRUITING

    Shenzhen, Guangdong, 518020, China

  • Sichuan Provincial People's Hospital

    NOT_YET_RECRUITING

    Chengdu, Sichuan, 610072, China

  • Sihui people's Hospital

    RECRUITING

    Zhaoqing, Guangdong, 526200, China

  • Taishan people's Hospital

    RECRUITING

    Taishan, Guangdong, 529200, China

  • The Eighth Affiliated Hospital, Sun Yat-Sen University

    RECRUITING

    Shenzhen, Guangdong, 518033, China

  • The Fifth Affiliated Hospital, Sun Yat-Sen University

    NOT_YET_RECRUITING

    Zhuhai, Guangdong, 519000, China

  • The First Affiliated Hospital of Guangzhou Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510120, China

  • The First Affiliated Hospital of Wenzhou Medical University

    NOT_YET_RECRUITING

    Wenzhou, Zhejiang, 325000, China

  • The First Affilicated Hospital of Xinjiang Medical University

    NOT_YET_RECRUITING

    Ürümqi, Xinjiang, 830054, China

  • The Second Affiliated Hospital of Guangdong Medical University

    NOT_YET_RECRUITING

    Zhanjiang, Guangdong, China

  • The Second Affiliated Hospital of Shantou university Medical College

    RECRUITING

    Shantou, Guangdong, 515041, China

  • The Second Affiliated Hospital, Sun Yat-Sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510235, China

  • The Second Clinical College of Hainan Medical University

    NOT_YET_RECRUITING

    Haikou, Hainan, 460106, China

  • The Second People's Hospital of Nanhai District

    RECRUITING

    Foshan, Guangdong, 528251, China

  • The Second Xiangya Hospital of Central South University

    NOT_YET_RECRUITING

    Changsha, Hunan, 410008, China

  • The Third Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hunan, 13787318063, China

  • The first Affiliated Hospital of Xi'an Jiaotong University

    NOT_YET_RECRUITING

    Xi’an, Shanxi, 710061, China

  • The first Affiliated Hospital, Sun Yat-Sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510080, China

  • West China Hospital

    NOT_YET_RECRUITING

    Chengdu, Sichuan, 610041, China

  • Wuhan Asia Heart Hospital

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430022, China

  • Yan'an Hospital of Kunming City

    NOT_YET_RECRUITING

    Kunming, Yunnan, 65005, China

  • Yue Bei People's Hospital

    RECRUITING

    Shaoguan, Guangdong, 512026, China

  • Zhongshan People's Hospital

    RECRUITING

    Zhongshan, Guangdong, 528403, China

  • Zhuhai people's Hospital

    NOT_YET_RECRUITING

    Zhuhai, Guangdong, 519000, China

  • Zhujiang Hospital of Southern Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510280, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.